Research Article

Early Changes in [18F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts

Figure 7

Ex vivo longitudinal imaging study of JIMT1 and SKOV3 xenografts. Graphic representation of GLUT1, pAkt, and pS6 at day 2 (light grey) and day 7 (dark grey) of treatment for (a, c, e) JIMT1 and (b, d, f) SKOV3 xenografts.